Cancer Epigenetics, Guns and Triggers: Targeting the Right Player via Nanotechnology Approach is a complete package that provides a comprehensive and thorough understanding of the key players that modulate the various steps of carcinogenesis and malignant progression of the disease and the critical targets to be exploited for developing novel modalities of diagnosis and therapeutics.
Since epigenetic aberrations can be potentially reversed and restored to their normal state through epigenetic therapy, the book also discusses the challenges and the future of the field with the cutting-edge revelations and limitations that this research endeavor can offer, thereby helping the readers to enhance their critical thinking and adopt strategies of therapeutic importance.
• Delivers a detailed and complete journey of how cancer develops, its genetics, as well as other internal and external factors that are contributors of carcinogenesis1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iii 6. Dedication - p. iii 7. Contributors - p. xvii 8. About the editors - p. xxi 9. Preface - p. xxii 10. Acknowledgments - p. xxii 11. Section 1: Overview of cancer, internal and external factors associated with cancer - p. xxii 12. Chapter 1. Overview of cancer: Mechanisms of carcinogenesis - p. 3 13. Chapter 2. Tumor metabolism and micronutrients: New insights to target malignant tumors - p. 35 14. Chapter 3. The role of one-carbon amino acids in tumor-immune metabolism: From oncogenesis to therapy - p. 51 15. Chapter 4. Environmental causes of cancer - p. 69 16. Chapter 5. Cancer stem cells—Challenges for cancer therapies - p. 93 17. Chapter 6. Carving a therapeutic niche for metastatic cancer: Opportunities and challenges - p. 127 18. Section 2: Epigenetics and its importance in cancer therapies - p. 141 19. Chapter 7. An overview of epigenetics and cancer - p. 145 20. Chapter 8. Metabolic adaptation and epigenetic modulations: Unraveling tumor plasticity under variable tumor microenvironment - p. 169 21. Chapter 9. Involvement of epigenetic modifications in cancer stem cells and chemoresistance - p. 199 22. Chapter 10. Cancer biomarkers: Where genetics meets epigenetics - p. 215 23. Chapter 11. Epigenetics approach in cancer treatment with focus on lung and breast cancer - p. 233 24. Chapter 12. Dietary components as epigenetic modifiers and their roles in cancer prevention - p. 260 25. Section 3: Nanomedicine targeting epigenetic machinery in cancer therapy - p. 276 26. Chapter 13. Harnessing plant-derived biosynthetic nanomaterials for epigenetic modulation in cancer therapy - p. 279 27. Chapter 14. Nanotechnology-enhanced immunotherapy for cancer - p. 297 28. Chapter 15. Nanoparticles in metastatic cancer treatment - p. 309 29. Chapter 16. Amine-terminated dendrimers: A novel method for diagnose, control and treatment of cancer - p. 333 30. Chapter 17. Nanomedicine and epigenome: Possible health risks, benefits, and future perspectives - p. 381 31. Chapter 18. Smart cancer nanomedicine: Challenges and future opportunities - p. 401 32. Index - p. 421
Cancer Epigenetics, Guns and Triggers: Targeting the Right Player via Nanotechnology Approach is a complete package that provides a comprehensive and thorough understanding of the key players that modulate the various steps of carcinogenesis and malignant progression of the disease and the critical targets to be exploited for developing novel modalities of diagnosis and therapeutics.
Since epigenetic aberrations can be potentially reversed and restored to their normal state through epigenetic therapy, the book also discusses the challenges and the future of the field with the cutting-edge revelations and limitations that this research endeavor can offer, thereby helping the readers to enhance their critical thinking and adopt strategies of therapeutic importance.
• Delivers a detailed and complete journey of how cancer develops, its genetics, as well as other internal and external factors that are contributors of carcinogenesis1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iii 6. Dedication - p. iii 7. Contributors - p. xvii 8. About the editors - p. xxi 9. Preface - p. xxii 10. Acknowledgments - p. xxii 11. Section 1: Overview of cancer, internal and external factors associated with cancer - p. xxii 12. Chapter 1. Overview of cancer: Mechanisms of carcinogenesis - p. 3 13. Chapter 2. Tumor metabolism and micronutrients: New insights to target malignant tumors - p. 35 14. Chapter 3. The role of one-carbon amino acids in tumor-immune metabolism: From oncogenesis to therapy - p. 51 15. Chapter 4. Environmental causes of cancer - p. 69 16. Chapter 5. Cancer stem cells—Challenges for cancer therapies - p. 93 17. Chapter 6. Carving a therapeutic niche for metastatic cancer: Opportunities and challenges - p. 127 18. Section 2: Epigenetics and its importance in cancer therapies - p. 141 19. Chapter 7. An overview of epigenetics and cancer - p. 145 20. Chapter 8. Metabolic adaptation and epigenetic modulations: Unraveling tumor plasticity under variable tumor microenvironment - p. 169 21. Chapter 9. Involvement of epigenetic modifications in cancer stem cells and chemoresistance - p. 199 22. Chapter 10. Cancer biomarkers: Where genetics meets epigenetics - p. 215 23. Chapter 11. Epigenetics approach in cancer treatment with focus on lung and breast cancer - p. 233 24. Chapter 12. Dietary components as epigenetic modifiers and their roles in cancer prevention - p. 260 25. Section 3: Nanomedicine targeting epigenetic machinery in cancer therapy - p. 276 26. Chapter 13. Harnessing plant-derived biosynthetic nanomaterials for epigenetic modulation in cancer therapy - p. 279 27. Chapter 14. Nanotechnology-enhanced immunotherapy for cancer - p. 297 28. Chapter 15. Nanoparticles in metastatic cancer treatment - p. 309 29. Chapter 16. Amine-terminated dendrimers: A novel method for diagnose, control and treatment of cancer - p. 333 30. Chapter 17. Nanomedicine and epigenome: Possible health risks, benefits, and future perspectives - p. 381 31. Chapter 18. Smart cancer nanomedicine: Challenges and future opportunities - p. 401 32. Index - p. 421
